GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (NYSE:BDX) » Definitions » EV-to-EBIT

BDX (Becton Dickinson) EV-to-EBIT : 38.17 (As of Oct. 31, 2024)


View and export this data going back to 1963. Start your Free Trial

What is Becton Dickinson EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Becton Dickinson's Enterprise Value is $82,403 Mil. Becton Dickinson's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $2,159 Mil. Therefore, Becton Dickinson's EV-to-EBIT for today is 38.17.

The historical rank and industry rank for Becton Dickinson's EV-to-EBIT or its related term are showing as below:

BDX' s EV-to-EBIT Range Over the Past 10 Years
Min: 15.31   Med: 40.42   Max: 117.11
Current: 38.17

During the past 13 years, the highest EV-to-EBIT of Becton Dickinson was 117.11. The lowest was 15.31. And the median was 40.42.

BDX's EV-to-EBIT is ranked worse than
78.08% of 447 companies
in the Medical Devices & Instruments industry
Industry Median: 19.79 vs BDX: 38.17

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Becton Dickinson's Enterprise Value for the quarter that ended in Jun. 2024 was $81,565 Mil. Becton Dickinson's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $2,159 Mil. Becton Dickinson's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 2.65%.


Becton Dickinson EV-to-EBIT Historical Data

The historical data trend for Becton Dickinson's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson EV-to-EBIT Chart

Becton Dickinson Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.12 85.86 38.64 35.85 42.35

Becton Dickinson Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.20 42.35 42.66 40.89 37.78

Competitive Comparison of Becton Dickinson's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Becton Dickinson's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's EV-to-EBIT falls into.



Becton Dickinson EV-to-EBIT Calculation

Becton Dickinson's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=82403.327/2159
=38.17

Becton Dickinson's current Enterprise Value is $82,403 Mil.
Becton Dickinson's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,159 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton Dickinson  (NYSE:BDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Becton Dickinson's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=2159/81565.00582
=2.65 %

Becton Dickinson's Enterprise Value for the quarter that ended in Jun. 2024 was $81,565 Mil.
Becton Dickinson's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,159 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton Dickinson EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton Dickinson Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Executives
Thomas J Spoerel officer: VP Controller & Chief Acct Off BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Roland Goette officer: EVP and President, EMEA BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Michael David Garrison officer: EVP and President Medical BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Richard Byrd officer: EVP & President Interventional BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Claire Fraser director C/O BECTON, DICKINSON AND COMPANY, FRANKLIN LAKES NJ 07465
David Hickey officer: EVP & President, Life Sciences BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Joanne Waldstreicher director C/O STRUCTURE THERAPEUTICS INC., 611 GATEWAY BLVD, SUITE 223, SOUTH SAN FRANCISCO CA 94080
Michelle Quinn officer: EVP and Acting General Counsel 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Shan officer: EVP, Integrated Supply Chain 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher Delorefice officer: EVP & CFO BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Polen Thomas E Jr officer: Executive Vice President BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Samrat S. Khichi officer: EVP and General Counsel C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Rishi Grover officer: EVP and Chief ISC Officer BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Pavan Kumar Mocherla officer: EVP and President Greater Asia BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
James C Lim officer: Executive Vice President BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417